HEADER CELL ADHESION 27-OCT-23 8USM TITLE FMLH LECTIN DOMAIN UTI89 - AM4085 COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIMBRIAL PROTEIN (FRAGMENT); COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LECTIN DOMAIN UTI89; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 GENE: G3W53_27805; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ADHESIN INHIBITOR, CELL ADHESION EXPDTA X-RAY DIFFRACTION AUTHOR K.O.TAMADONFAR,J.P.PINKNER,A.R.MADDIRALA,J.W.JANETKA,S.J.HULTGREN REVDAT 2 27-MAR-24 8USM 1 JRNL REVDAT 1 14-FEB-24 8USM 0 JRNL AUTH A.R.MADDIRALA,K.TAMADONFAR,J.S.PINKNER,D.SANICK, JRNL AUTH 2 S.J.HULTGREN,J.W.JANETKA JRNL TITL DISCOVERY OF ORALLY BIOAVAILABLE FMLH LECTIN ANTAGONISTS AS JRNL TITL 2 TREATMENT FOR URINARY TRACT INFECTIONS. JRNL REF J.MED.CHEM. V. 67 3668 2024 JRNL REFN ISSN 0022-2623 JRNL PMID 38308631 JRNL DOI 10.1021/ACS.JMEDCHEM.3C02128 REMARK 2 REMARK 2 RESOLUTION. 1.63 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.13_2998 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.63 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.47 REMARK 3 MIN(FOBS/SIGMA_FOBS) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 38858 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2007 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 1.6880 - 1.6300 1.00 3807 187 0.2017 0.2527 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.11 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 2441 REMARK 3 ANGLE : 0.908 3352 REMARK 3 CHIRALITY : 0.052 381 REMARK 3 PLANARITY : 0.005 420 REMARK 3 DIHEDRAL : 9.713 1370 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 7.4945 13.4800 6.8714 REMARK 3 T TENSOR REMARK 3 T11: 0.1143 T22: 0.0959 REMARK 3 T33: 0.1001 T12: 0.0113 REMARK 3 T13: -0.0001 T23: 0.0134 REMARK 3 L TENSOR REMARK 3 L11: 1.2263 L22: 0.5384 REMARK 3 L33: 0.0432 L12: -0.2123 REMARK 3 L13: 0.0389 L23: -0.0504 REMARK 3 S TENSOR REMARK 3 S11: -0.0446 S12: -0.0384 S13: 0.0494 REMARK 3 S21: 0.0385 S22: 0.0396 S23: 0.0032 REMARK 3 S31: -0.0421 S32: -0.0188 S33: -0.0015 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8USM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-OCT-23. REMARK 100 THE DEPOSITION ID IS D_1000278331. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-AUG-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 4.2.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CMOS REMARK 200 DETECTOR MANUFACTURER : RDI CMOS_8M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38858 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.630 REMARK 200 RESOLUTION RANGE LOW (A) : 38.470 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 7.100 REMARK 200 R MERGE (I) : 0.05884 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.7600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.63 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.30 REMARK 200 R MERGE FOR SHELL (I) : 0.36940 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.890 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.7 M LISO4 2% PEG 8000, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 25.62250 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 58.22500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.62250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 58.22500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 65 REMARK 465 SER A 66 REMARK 465 VAL A 111 REMARK 465 GLY A 112 REMARK 465 ALA A 113 REMARK 465 ALA A 114 REMARK 465 GLY A 115 REMARK 465 PRO A 157 REMARK 465 THR A 158 REMARK 465 GLY A 159 REMARK 465 GLY A 160 REMARK 465 HIS A 161 REMARK 465 HIS A 162 REMARK 465 HIS A 163 REMARK 465 HIS A 164 REMARK 465 HIS A 165 REMARK 465 HIS A 166 REMARK 465 VAL B 111 REMARK 465 GLY B 112 REMARK 465 ALA B 113 REMARK 465 ALA B 114 REMARK 465 HIS B 161 REMARK 465 HIS B 162 REMARK 465 HIS B 163 REMARK 465 HIS B 164 REMARK 465 HIS B 165 REMARK 465 HIS B 166 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL A 25 CG1 CG2 REMARK 470 GLN A 68 CG CD OE1 NE2 REMARK 470 LYS A 71 CG CD CE NZ REMARK 470 GLN B 30 CG CD OE1 NE2 REMARK 470 GLN B 68 CG CD OE1 NE2 REMARK 470 LYS B 120 NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 39 -40.25 -132.28 REMARK 500 GLN A 59 133.96 -37.07 REMARK 500 ASN A 78 5.65 80.67 REMARK 500 ALA A 134 -151.02 -94.16 REMARK 500 HIS B 39 -31.53 -131.94 REMARK 500 GLN B 59 135.14 -38.11 REMARK 500 ALA B 134 -150.27 -92.57 REMARK 500 REMARK 500 REMARK: NULL DBREF1 8USM A 1 160 UNP A0A8T6QH46_ECOLX DBREF2 8USM A A0A8T6QH46 25 184 DBREF1 8USM B 1 160 UNP A0A8T6QH46_ECOLX DBREF2 8USM B A0A8T6QH46 25 184 SEQADV 8USM HIS A 161 UNP A0A8T6QH4 EXPRESSION TAG SEQADV 8USM HIS A 162 UNP A0A8T6QH4 EXPRESSION TAG SEQADV 8USM HIS A 163 UNP A0A8T6QH4 EXPRESSION TAG SEQADV 8USM HIS A 164 UNP A0A8T6QH4 EXPRESSION TAG SEQADV 8USM HIS A 165 UNP A0A8T6QH4 EXPRESSION TAG SEQADV 8USM HIS A 166 UNP A0A8T6QH4 EXPRESSION TAG SEQADV 8USM HIS B 161 UNP A0A8T6QH4 EXPRESSION TAG SEQADV 8USM HIS B 162 UNP A0A8T6QH4 EXPRESSION TAG SEQADV 8USM HIS B 163 UNP A0A8T6QH4 EXPRESSION TAG SEQADV 8USM HIS B 164 UNP A0A8T6QH4 EXPRESSION TAG SEQADV 8USM HIS B 165 UNP A0A8T6QH4 EXPRESSION TAG SEQADV 8USM HIS B 166 UNP A0A8T6QH4 EXPRESSION TAG SEQRES 1 A 166 PHE SER CYS ASN VAL ASP GLY GLY SER SER ILE GLY ALA SEQRES 2 A 166 GLY THR THR SER VAL TYR VAL ASN LEU ASP PRO VAL ILE SEQRES 3 A 166 GLN PRO GLY GLN ASN LEU VAL VAL ASP LEU SER GLN HIS SEQRES 4 A 166 ILE SER CYS TRP ASN ASP TYR GLY GLY TRP TYR ASP THR SEQRES 5 A 166 ASP HIS ILE ASN LEU VAL GLN GLY SER ALA PHE ALA GLY SEQRES 6 A 166 SER LEU GLN SER TYR LYS GLY SER LEU TYR TRP ASN ASN SEQRES 7 A 166 VAL THR TYR PRO PHE PRO LEU THR THR ASN THR ASN VAL SEQRES 8 A 166 LEU ASP ILE GLY ASP LYS THR PRO MET PRO LEU PRO LEU SEQRES 9 A 166 LYS LEU TYR ILE THR PRO VAL GLY ALA ALA GLY GLY VAL SEQRES 10 A 166 VAL ILE LYS ALA GLY GLU VAL ILE ALA ARG ILE HIS MET SEQRES 11 A 166 TYR LYS ILE ALA THR LEU GLY SER GLY ASN PRO ARG ASN SEQRES 12 A 166 PHE THR TRP ASN ILE ILE SER ASN ASN SER VAL VAL MET SEQRES 13 A 166 PRO THR GLY GLY HIS HIS HIS HIS HIS HIS SEQRES 1 B 166 PHE SER CYS ASN VAL ASP GLY GLY SER SER ILE GLY ALA SEQRES 2 B 166 GLY THR THR SER VAL TYR VAL ASN LEU ASP PRO VAL ILE SEQRES 3 B 166 GLN PRO GLY GLN ASN LEU VAL VAL ASP LEU SER GLN HIS SEQRES 4 B 166 ILE SER CYS TRP ASN ASP TYR GLY GLY TRP TYR ASP THR SEQRES 5 B 166 ASP HIS ILE ASN LEU VAL GLN GLY SER ALA PHE ALA GLY SEQRES 6 B 166 SER LEU GLN SER TYR LYS GLY SER LEU TYR TRP ASN ASN SEQRES 7 B 166 VAL THR TYR PRO PHE PRO LEU THR THR ASN THR ASN VAL SEQRES 8 B 166 LEU ASP ILE GLY ASP LYS THR PRO MET PRO LEU PRO LEU SEQRES 9 B 166 LYS LEU TYR ILE THR PRO VAL GLY ALA ALA GLY GLY VAL SEQRES 10 B 166 VAL ILE LYS ALA GLY GLU VAL ILE ALA ARG ILE HIS MET SEQRES 11 B 166 TYR LYS ILE ALA THR LEU GLY SER GLY ASN PRO ARG ASN SEQRES 12 B 166 PHE THR TRP ASN ILE ILE SER ASN ASN SER VAL VAL MET SEQRES 13 B 166 PRO THR GLY GLY HIS HIS HIS HIS HIS HIS HET XC8 A 201 53 HET XC8 B 201 53 HETNAM XC8 4'-FLUORO-6-(TRIFLUOROMETHYL)[1,1'-BIPHENYL]-2-YL 2- HETNAM 2 XC8 ACETAMIDO-2-DEOXY-BETA-D-GALACTOPYRANOSIDE FORMUL 3 XC8 2(C21 H21 F4 N O6) FORMUL 5 HOH *72(H2 O) HELIX 1 AA1 GLY B 65 GLN B 68 5 4 SHEET 1 AA1 3 SER A 2 VAL A 5 0 SHEET 2 AA1 3 ILE A 40 TRP A 43 -1 O TRP A 43 N SER A 2 SHEET 3 AA1 3 MET A 100 PRO A 101 -1 O MET A 100 N CYS A 42 SHEET 1 AA2 4 GLY A 14 VAL A 20 0 SHEET 2 AA2 4 ARG A 142 SER A 150 1 O ILE A 149 N VAL A 20 SHEET 3 AA2 4 VAL A 124 ILE A 133 -1 N MET A 130 O PHE A 144 SHEET 4 AA2 4 ALA A 62 PHE A 63 -1 N ALA A 62 O ARG A 127 SHEET 1 AA3 5 GLY A 14 VAL A 20 0 SHEET 2 AA3 5 ARG A 142 SER A 150 1 O ILE A 149 N VAL A 20 SHEET 3 AA3 5 VAL A 124 ILE A 133 -1 N MET A 130 O PHE A 144 SHEET 4 AA3 5 ASP A 53 LEU A 57 -1 N ASN A 56 O TYR A 131 SHEET 5 AA3 5 LEU A 92 ILE A 94 -1 O LEU A 92 N ILE A 55 SHEET 1 AA4 4 LEU A 32 ASP A 35 0 SHEET 2 AA4 4 LEU A 104 THR A 109 -1 O ILE A 108 N LEU A 32 SHEET 3 AA4 4 LYS A 71 TRP A 76 -1 N SER A 73 O TYR A 107 SHEET 4 AA4 4 VAL A 79 PHE A 83 -1 O TYR A 81 N LEU A 74 SHEET 1 AA5 2 VAL A 117 ILE A 119 0 SHEET 2 AA5 2 VAL A 154 VAL A 155 -1 O VAL A 154 N VAL A 118 SHEET 1 AA6 3 SER B 2 VAL B 5 0 SHEET 2 AA6 3 ILE B 40 TRP B 43 -1 O TRP B 43 N SER B 2 SHEET 3 AA6 3 MET B 100 PRO B 101 -1 O MET B 100 N CYS B 42 SHEET 1 AA7 4 GLY B 14 VAL B 20 0 SHEET 2 AA7 4 ARG B 142 SER B 150 1 O ASN B 147 N VAL B 18 SHEET 3 AA7 4 VAL B 124 ILE B 133 -1 N MET B 130 O PHE B 144 SHEET 4 AA7 4 ALA B 62 PHE B 63 -1 N ALA B 62 O ARG B 127 SHEET 1 AA8 5 GLY B 14 VAL B 20 0 SHEET 2 AA8 5 ARG B 142 SER B 150 1 O ASN B 147 N VAL B 18 SHEET 3 AA8 5 VAL B 124 ILE B 133 -1 N MET B 130 O PHE B 144 SHEET 4 AA8 5 ASP B 53 LEU B 57 -1 N ASN B 56 O TYR B 131 SHEET 5 AA8 5 LEU B 92 ILE B 94 -1 O LEU B 92 N ILE B 55 SHEET 1 AA9 4 LEU B 32 ASP B 35 0 SHEET 2 AA9 4 LEU B 104 ILE B 108 -1 O ILE B 108 N LEU B 32 SHEET 3 AA9 4 GLY B 72 TRP B 76 -1 N TYR B 75 O LYS B 105 SHEET 4 AA9 4 VAL B 79 PHE B 83 -1 O TYR B 81 N LEU B 74 SHEET 1 AB1 2 GLY B 116 ILE B 119 0 SHEET 2 AB1 2 VAL B 154 MET B 156 -1 O VAL B 154 N VAL B 118 SSBOND 1 CYS A 3 CYS A 42 1555 1555 2.05 SSBOND 2 CYS B 3 CYS B 42 1555 1555 2.03 CISPEP 1 PHE A 83 PRO A 84 0 6.92 CISPEP 2 PHE B 83 PRO B 84 0 6.13 CRYST1 51.245 116.450 50.955 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019514 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008587 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019625 0.00000